Bluesight Unveils Innovative Solution for Drug Shortages

Bluesight Introduces ShortageCheck to Combat Drug Shortages

New technology empowers healthcare systems with proactive measures against drug shortages.

Bluesight, known for its innovative hospital intelligence solutions, has rolled out ShortageCheck, a pivotal technology aimed at aiding hospitals and health systems in predicting and managing drug shortages effectively. This powerful platform combines advanced predictive analytics, current inventory data, and collaborative planning functionalities to address potential disruptions before they impact patient care.

The emergence of ShortageCheck is particularly timely as recent reports indicate that 75% of healthcare professionals view drug shortages as one of their chief concerns that hinder efficiency and compliance. Moreover, research highlights a staggering rise in the time and expenses associated with managing these shortages—an increase that has seen costs soar to nearly $900 million annually.

ShortageCheck provides real-time monitoring capabilities, tracking over 20 critical market indicators, including shifts in demand and fulfillment challenges across over 2,500 hospitals. The system not only identifies early warning signs of potential drug shortages but also forecasts these shortages, providing crucial lead times of up to 90 days, with an average of 42 days. Such foresight equips hospitals and health systems with the necessary time to devise plans and avert interruptions in patient care.

Kevin MacDonald, CEO and co-founder of Bluesight, emphasizes the importance of this innovation, stating, "Shortage management has become a significant pain point for our clients. When faced with unexpected shortages, hospital teams are often left scrambling for solutions, which ultimately jeopardizes patient care. By launching ShortageCheck, we are addressing this issue head-on, allowing healthcare providers to manage their resources efficiently, especially in a climate of rising drug costs and persistent staff shortages."

ShortageCheck expands Bluesight's comprehensive suite of Hospital Intelligence solutions, which aims to simplify complex healthcare operations. Other offerings such as KitCheck, CostCheck, and 340BCheck complement ShortageCheck, enabling clients to restock inventory faster, cut unnecessary spending, and streamline audit preparations significantly.

For hospitals seeking to improve their operations and mitigate the risks associated with drug shortages, Bluesight offers a suite of intelligent solutions, which include tools that enable more efficient inventory management and compliance. With a commitment to protecting patient safety and optimizing financial resources, Bluesight asserts that over 2,400 hospitals in both the United States and Canada trust them to enhance their operational capabilities daily.

For additional details on ShortageCheck and how it can transform hospital drug inventory management, visit Bluesight's website.

Frequently Asked Questions

What is ShortageCheck?

ShortageCheck is Bluesight's innovative solution designed to help hospitals predict and manage drug shortages before they impact patient care.

How does ShortageCheck work?

The platform continuously analyzes more than 20 market indicators to forecast potential drug shortages, giving hospitals ample time to prepare.

Why are drug shortages a significant concern for hospitals?

Drug shortages can severely affect patient care and operational efficiency, leading to increased costs and complexities in managing inventories.

What are some additional tools offered by Bluesight?

Along with ShortageCheck, Bluesight provides solutions like KitCheck, CostCheck, and 340BCheck, aimed at improving various aspects of hospital operations.

How many hospitals rely on Bluesight solutions?

Over 2,400 hospitals in the United States and Canada depend on Bluesight for efficient inventory management and operational safety.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.